**Amarantus Biosciences** hebt ab
neuester Beitrag 14.04.16 07:52:54 von
Amarantus BioSciences Explores Orphan Drug Strategy Based on MANF Protein Folding
SUNNYVALE, Calif., Nov. 1, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centred on its proprietary anti-apoptosis therapeutic protein MANF, today announced that it intends to pursue the identification of one or multiple therapeutic indications for its lead therapeutic candidate MANF that could lead to the therapy receiving orphan drug designation(s) with the Food and Drug Administration (FDA). The strategy is centred on exploiting MANF's unique mechanism of action related to facilitating proper protein folding and processing in the endoplasmic reticulum in order to identify rare and/or ultra-rare diseases where MANF treatment may play a significant role in improving patient outcomes in disease states where no other treatment options are currently available.
jeder sollte das berücksichtigen.
obwohl schon mehr als 500% vom Tief gemacht.
Ist bei OTC bzw. Pink Werten nicht ungewöhnlich
....WARP 9 INC (PINK:WNYN) surged sharply as it started trading today. It gained more than 52% and its overall 5 days movement remained incredible, it gained more than 1345% in the last 5 days......
da musste bei ner Daimleraktie Jahrelang/Jahrzehntelang warten